ArticleJournal of orthopaedic surgery and research2022
Single posterior approach for circumferential debridement and anterior reconstruction using fibular allograft in patients with skipped multifocal spinal tuberculosis.
Article in Journal of orthopaedic surgery and research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 4 citations in OpenAlex.
- Comparative Clinical Efficacy and Safety of Multi-Segment Thoracolumbar Tuberculosis Treated Through the Posterior "Detour Method" Versus the Combined Anterior-Posterior Approach: A Technique Note and Preliminary Retrospective Study.Orthopaedic surgery · 2026Article
- Epidemiological and osteoarticular involvement sites' characteristics of multiple osteoarticular tuberculosis: a scoping review.Epidemiology and infection · 2025Article
- Reconstruction of complicated spinal tuberculosis with long-segment fibula transplantation: a case report.BMC musculoskeletal disorders · 2023Article
- The Use of Free Vascularized Fibula Graft in Spinal Reconstruction: A Comprehensive Systematic Review.Plastic and reconstructive surgery. Global open · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSkipped multifocal spinal tuberculosis (TB) is an atypical presentation of spinal TB. Surgical treatment for these unusual cases remains a challenge for spine surgeons. In our institute, we used single-stage circumferential debridement and anterior reconstruction with fibular allograft followed by posterior instrumentation through posterior-only approach for these patients. This study aimed to determine the efficacy and feasibility of this technique.
methodsTwelve patients with skipped multifocal spinal TB who received our treatment method from January 2012 to June 2020 were enrolled in this study. The visual analog score (VAS), laboratory data, comorbidities, complications, and neurologic status based on Frankel scale were recorded. The patients' clinical conditions were evaluated based on modified Brodsky's criteria and Oswestry Disability Index (ODI).
resultsAll the patients were infection free at the end of the treatment. The average VAS score was 7.5 (range, 7-8) before surgery and decreased to 2.1 (range, 1-3) one year postoperatively. No one experienced any severe complications such as neurologic deterioration, fixation failure, or bone graft dislodgement. Out of the three patients requiring debridement surgery, two had wound infection and one had seroma formation. The ODI score improved from 76.8 (range, 70-84) preoperatively to 25.5 (range, 22-28) one year after surgery. All patients achieved good or excellent outcome based on modified Brodsky's criteria one year postoperatively.
conclusionsIn our study, the patients could achieve a good clinical outcome. This technique could be an alternative for patients with skipped spinal TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.